West Pharmaceutical Servs (NYSE:WST) reported quarterly earnings results on February 12, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per…
West Pharmaceutical Servs (NYSE:WST) reported quarterly earnings results on February 12, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $2.04, beating the consensus estimate of $1.83 by $0.21 per share. Revenue came in at $805.0M, beating the estimate of $794.6M.
West Pharmaceutical Servs's stock moved following the earnings release. The stock currently trades at $250.49 with a market capitalization of $19.6B.
Current market data
NYSE · WST
$341.11
Up: +$3.64 · +1.08%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
dividends ·
analyst ·
sec_filing ·
earnings ·
